Erfurt, D-99084, Germany
NCT Number: NCT01861626
Bioequivalence Study of V0057 Versus a Reference Formulation After Single Administration in Healthy Male Subjects
The purpose of this study is to evaluate the bioequivalence (comparison of the rate and extent of the active substance into the body following single administration of the drugs) between the test product V0057 and a reference product after two single oral administration separate by 7 days.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–50 year
Sex eligibility
Male
Study type
Interventional
Phase
Phase 1
Primary location
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Healthy male subject aged 18 to 50 years (inclusive)
Exclusion criteria
- Presence of any significant medical finding or significant history that may impact the safety, the interpretation of the results and/or the participation of the subject in the study according to the opinion of the investigator
- Presence of any clinically significant abnormal finding at examination in the Investigator's opinion
Treatment and study plan
V0057 - A mg
DrugSingle oral administration
isotretinoin
DrugSingle oral administration
Primary outcomes
-
Maximum Plasma Concentration (Cmax)
Time frame: 18 time points up to 72h after administration
-
Time of Maximum Concentration (Tmax)
Time frame: 18 time points up to 72h after administration
-
Area under curve (AUC0-72)
Time frame: 18 time points up to 72h after administration
Sponsors and collaborators
Lead sponsor
Pierre Fabre Dermatology
Industry
Registry information
Important dates
- Study start
- 2013
- Primary completion
- 2013
- Study completion
- 2013
- First posted
- May 23, 2013
- Registry last updated
- Jun 19, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Spirulina Oral Supplement for Enhancing Host Resilience to Virus Infection
NCT05447078
Healthy Volunteers, Infections
Jackson, Mississippi, United States
View Trial DetailsThe Primary Purpose of This Study is to Determine if Biotin, Vitamin B7 is an Effective Way to Label Platelets in Survival and Recovery Studies.
NCT07513532
Healthy Volunteers
Seattle, Washington, United States
View Trial DetailsA Phase 1 Study of Budoprutug (TNT119) Subcutaneous and Intravenous Injections in Normal Healthy Volunteers
NCT07090655
Healthy Volunteers
Brisbane, Australia
View Trial DetailsStudy of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection
NCT01915212
Communicable Diseases, DNA Virus Infections
Bethesda, Maryland, United States
View Trial Details